Home
Conditions
Oligodendroglioma

Clinical trial condition

Oligodendroglioma

Explore clinical trials studying Oligodendroglioma. Study availability and eligibility vary by location and protocol.

40 public trials 14 recruiting studies

Refine in advanced search Browse all conditions

Oligodendroglioma trial results

Completed

RRx-001 + Radiation + Temozolomide In Newly Diagnosed Glioblastoma and Anaplastic Gliomas

NCT02871843

Conditions: Anaplastic Oligodendroglioma, Astrocytoma, Glioblastoma, +9 more
Locations: University of California San Francisco (UCSF) San Francisco, California, United States

The Cancer Institute of New Jersey (Rutgers University) New Brunswick, New Jersey, United States

Weill Cornell Brain Tumor Center New York, United States

View Trial Details

Completed

Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors

NCT02747407

Conditions: Astrocytoma, Glioma, Neoplasms, +7 more
Locations: Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States

View Trial Details

Completed

Neural Basis of Language Processing

NCT02903784

Conditions: Astrocytoma, Glioma, Neoplasms, +8 more
Locations: Not specified

View Trial Details

Completed

Natural History of Patients With Brain and Spinal Cord Tumors

NCT00009035

Conditions: Anaplastic Glioma, Astrocytoma, Central Nervous System Neoplasms, +15 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601)

NCT00392171

Conditions: Astrocytoma, Glioblastoma, Glioma, +8 more
Locations: Not specified

View Trial Details

Completed

HLA-A2-Restricted Glioma Antigen-Peptides Vaccinations With Poly-ICLC for Recurrent WHO Grade II Gliomas

NCT00874861

Conditions: Astrocytoma, Glioma, Neoplasms, +8 more
Locations: UPMC Hillman Cancer Center (University of Pittsburgh Cancer Institute) Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Efficacy of Protracted Temozolomide in Patients With Progressive High Grade Glioma

NCT00575887

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +16 more
Locations: Marmara University Hospital Istanbul, Turkey (Türkiye)

View Trial Details

Completed

Prolonged Daily Temozolomide for Low-Grade Glioma

NCT00165360

Conditions: Astrocytoma, Glioma, Neoplasms, +7 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas

NCT00080054

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasm, +16 more
Locations: Barrow Neurological Institute Phoenix, Arizona, United States

View Trial Details

Completed

Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide

NCT00717210

Conditions: Anaplastic Astrocytoma, Astrocytoma, Glioma, +9 more
Locations: University of Heidelberg Heidelberg, Baden-Wurttemberg, Germany

Neurology and Radiotherapy Tübingen, Baden-Wurttemberg, Germany

Klinikum Aschaffenburg Aschaffenburg, Germany

Nervenklinik Bamberg, Germany

View Trial Details

Oligodendroglioma

Oligodendroglioma trial results

Related conditions